Marc H. Hedrick - 01 Apr 2026 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
01 Apr 2026, 07:30:03 UTC
Prior SEC filing
27 Feb 2026
Next SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Andrew Sims, as attorney-in-fact

Key filing fact

Marc H. Hedrick filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 01 Apr 2026.

Key facts

  • This page summarizes Marc H. Hedrick's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 01 Apr 2026, 07:30.

Change

  • Previous filing in this sequence was filed on 27 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001203672 Primary reporting owner

HEDRICK MARC H

Relationship
Chief Executive Officer, Director
Address
C/O PLUS THERAPEUTICS INC., 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
Signature
Andrew Sims, as attorney-in-fact
Signature date
01 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PSTV transaction

Common Stock

Options Exercise

Transaction value
Shares
+159,681
Change %
+47%
Price
$0.000000*
Shares after
499,468
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1, F2
PSTV transaction

Common Stock

Options Exercise

Transaction value
Shares
-201,632
Change %
-22%
Price
$0.000000*
Shares after
701,100
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PSTV transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-159,681
Change %
-4%
Price
$0.000000*
Shares after
3,856,707
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
159,681
Exercise price
$0.000000
Footnotes
F2
PSTV transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-201,632
Change %
-5.2%
Price
$0.000000*
Shares after
3,655,075
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
201,632
Exercise price
$0.000000
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.

Footnote F2

Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on October 1, 2025.

Footnote F3

Represents the vesting of an RSU grant which occurs in twelve substantially equal quarterly installments beginning on April 1, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .